Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
Department of Pathology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
J Diabetes Res. 2020 Jan 29;2020:4981814. doi: 10.1155/2020/4981814. eCollection 2020.
As a chronic metabolic disease, diabetes mellitus (DM) is broadly characterized by elevated levels of blood glucose. Novel epidemiological studies demonstrate that some diabetic patients have an increased risk of developing dementia compared with healthy individuals. Alzheimer's disease (AD) is the most frequent cause of dementia and leads to major progressive deficits in memory and cognitive function. Multiple studies have identified an increased risk for AD in some diabetic populations, but it is still unclear which diabetic patients will develop dementia and which biological characteristics can predict cognitive decline. Although few mechanistic metabolic studies have shown clear pathophysiological links between DM and AD, there are several plausible ways this may occur. Since AD has many characteristics in common with impaired insulin signaling pathways, AD can be regarded as a metabolic disease. We conclude from the published literature that the body's diabetic status under certain circumstances such as metabolic abnormalities can increase the incidence of AD by affecting glucose transport to the brain and reducing glucose metabolism. Furthermore, due to its plentiful lipid content and high energy requirement, the brain's metabolism places great demands on mitochondria. Thus, the brain may be more susceptible to oxidative damage than the rest of the body. Emerging evidence suggests that both oxidative stress and mitochondrial dysfunction are related to amyloid- (A) pathology. Protein changes in the unfolded protein response or endoplasmic reticulum stress can regulate A production and are closely associated with tau protein pathology. Altogether, metabolic disorders including glucose/lipid metabolism, oxidative stress, mitochondrial dysfunction, and protein changes caused by DM are associated with an impaired insulin signal pathway. These metabolic factors could increase the prevalence of AD in diabetic patients via the promotion of A pathology.
作为一种慢性代谢性疾病,糖尿病(DM)的特征通常为血糖水平升高。新的流行病学研究表明,与健康个体相比,一些糖尿病患者发生痴呆的风险增加。阿尔茨海默病(AD)是痴呆症最常见的病因,导致记忆和认知功能的严重进行性衰退。多项研究已经确定了一些糖尿病患者发生 AD 的风险增加,但仍不清楚哪些糖尿病患者会发展为痴呆症,哪些生物学特征可以预测认知能力下降。尽管一些机制代谢研究已经明确了 DM 和 AD 之间存在明显的病理生理学联系,但仍有几种可能的发生方式。由于 AD 与受损的胰岛素信号通路有许多共同特征,因此可以将 AD 视为一种代谢疾病。我们从已发表的文献中得出结论,在某些情况下,例如代谢异常,机体的糖尿病状态可能会通过影响葡萄糖向大脑的转运并降低葡萄糖代谢来增加 AD 的发病率。此外,由于大脑富含脂质且能量需求高,其代谢对线粒体的要求很高。因此,大脑可能比身体其他部位更容易受到氧化损伤。新出现的证据表明,氧化应激和线粒体功能障碍都与淀粉样蛋白(A)病理学有关。未折叠蛋白反应或内质网应激中的蛋白质变化可以调节 A 的产生,并且与 tau 蛋白病理学密切相关。总的来说,包括葡萄糖/脂质代谢、氧化应激、线粒体功能障碍和 DM 引起的蛋白质变化在内的代谢紊乱与胰岛素信号通路受损有关。这些代谢因素可能会通过促进 A 病理学来增加糖尿病患者 AD 的患病率。